Home / Osteopontin/OPN / Recombinant Human Osteopontin (OPN) Protein

Recombinant Human Osteopontin (OPN) Protein

Catalog #: 1433-OP
43 Citations 2 Reviews Datasheet
(OPN-b)

Carrier Free

Catalog # Availability Size / Price Qty
1433-OP-050/CF

With Carrier

Catalog # Availability Size / Price Qty
1433-OP-050
Recombinant Human Osteopontin (OPN) Protein Bioactivity
2 Images
Product Details
Citations (43)
FAQs
Supplemental Products
Reviews (2)
Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Human Osteopontin (OPN) Protein Summary

Product Specifications

Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity

Measured by the ability of the immobilized protein to support the adhesion of HEK293 human embryonic kidney cells. The ED50 for this effect is 0.100-0.600 µg/mL.

Source
Mouse myeloma cell line, NS0-derived human Osteopontin/OPN protein
Ile17-Asn300, with a C-terminal 6-His tag
Accession #
NP_000573.1
N-terminal Sequence
Analysis
Ile17
Predicted Molecular Mass
32.9 kDa
SDS-PAGE
60-65 kDa, reducing conditions

Product Datasheets

You must select a language.

x

1433-OP (with carrier)

Product Datasheet

You must select a language.

x

1433-OP/CF (carrier free)

Product Datasheet

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

1433-OP

Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Reconstitution Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

1433-OP/CF

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 100 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Scientific Data

Bioactivity Recombinant Human Osteopontin (OPN) Protein Bioactivity View Larger

Recombinant Human Osteopontin/OPN (Catalog # 1433‑OP), when immobilized, supports the adhesion of the HEK293 human embryonic kidney cells.

SDS-PAGE Recombinant Human Osteopontin (OPN) Protein SDS-PAGE View Larger

1 μg/lane of Recombinant Human Osteopontin/OPN was resolved with SDS-PAGE under reducing (R) conditions and visualized by silver staining, showing a bands at 60-65 kDa.

Background: Osteopontin/OPN

Osteopontin (OPN), previously called SPP1 (secreted phosphoprotein 1), Eta-1 (early T lymphocyte activation 1) or BSP (bone sialoprotein), is a secreted molecule in the SIBLING (small integrin-binding ligand N-linked glycoprotein) family of non-collagenous matricellular proteins (1-3). Human OPN is synthesized as a 317 amino acid (aa) precursor protein with a 16 aa signal peptide and a 301 aa mature protein (3). Mature human OPN shares 64% and 62% aa sequence identity with mouse and rat OPN, respectively. OPN is highly acidic and has 26 potential Ser/Thr phosphorylation sites and a C-terminal CD44 binding site (1-4). Depending on
tissue-specific modification by O- and N-glycosylation, sulfation, phosphorylation and transglutamination, OPN can be detected at 45-75 kDa (5, 6). The central region of OPN contains RGD and non-RGD binding sites for multiple integrins (3, 4). Adjacent to the RGD motif is the sequence SVVYGLR (SLAYGLR in mouse) which serves as a cryptic binding site for additional integrins: it is masked in full length OPN but is exposed following OPN cleavage by thrombin in tumors and sites of tissue injury (6-8). OPN can also be cleaved by MMP-3, -7, -9, and -12 within the SVVYGLR motif and at sites closer to the C-terminus (8, 9). OPN is widely expressed and is prominent in mineralized tissues. It inhibits bone mineralization and kidney stone formation, and promotes inflammation and cell adhesion and migration (1, 2, 4, 6). Its expression is up‑regulated during inflammation, obesity, atherosclerosis, cancer, and tissue damage, and contributes to the pathophysiology of these conditions (1, 2, 6, 9, 10).

References
  1. Scatena, M. et al. (2007) Arterioscler. Thromb. Vasc. Biol. 27:2302.
  2. Rangaswami, H. et al. (2006) Trends Cell Biol. 16:79.
  3. Young, M.F. et al. (1990) Genomics 7:491.
  4. Weber, G.F. et al. (2002) J. Leukoc. Biol. 72:752.
  5. Keykhosravani, M. et al. (2005) Biochemistry 44:6990.
  6. Kazanecki, C.C. et al. (2007) J. Cell. Biochem. 102:912.
  7. Senger, D.R. et al. (1994) Mol. Biol. Cell 5:565.
  8. Yokosaki, Y. et al. (2005) Matrix Biol. 24:418.
  9. Takafuji, V. et al. (2007) Oncogene 26:6361.
  10. Kiefer, F.W. et al. (2010) Diabetes 59:935.
Long Name
Secreted Phosphoprotein 1 [BNSP]
Entrez Gene IDs
6696 (Human); 20750 (Mouse); 25353 (Rat); 281499 (Bovine)
Alternate Names
BNSP; Bone sialoprotein 1; Eta-1; MGC110940; Nephropontin; OPN; Osteopontin; secreted phosphoprotein 1bone sialoprotein I, early T-lymphocyteactivation 1); secreted phosphoprotein-1 (osteopontin, bone sialoprotein); Spp1; SPP-1; SPP1/CALPHA1 fusion; Urinary stone protein; uropontin

Citations for Recombinant Human Osteopontin (OPN) Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

43 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Single-cell RNA sequencing reveals the CRTAC1+ population actively contributes to the pathogenesis of spinal ligament degeneration by SPP1+ macrophage
    Authors: Tang, Y;Zhuo, D;Yu, Y;Pu, W;Ma, Y;Zhang, Y;Huang, Y;Zhang, Q;Tang, K;Meng, C;Yang, D;Bai, L;He, D;Jin, L;Zou, H;Xu, H;Zhu, Q;Wang, J;Chen, Y;Liu, J;
    Aging cell
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  2. The CEBPB+ glioblastoma subcluster specifically drives the formation of M2 tumor-associated macrophages to promote malignancy growth
    Authors: Yang, Y;Jin, X;Xie, Y;Ning, C;Ai, Y;Wei, H;Xu, X;Ge, X;Yi, T;Huang, Q;Yang, X;Jiang, T;Wang, X;Piao, Y;Jin, X;
    Theranostics
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  3. An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma
    Authors: Yang, F;Akhtar, MN;Zhang, D;El-Mayta, R;Shin, J;Dorsey, JF;Zhang, L;Xu, X;Guo, W;Bagley, SJ;Fuchs, SY;Koumenis, C;Lathia, JD;Mitchell, MJ;Gong, Y;Fan, Y;
    Science advances
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  4. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis
    Authors: Ji, J;Zheng, S;Liu, Y;Xie, T;Zhu, X;Nie, Y;Shen, Y;Han, X;
    Journal of translational medicine
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  5. A Dual Role of Osteopontin in Modifying B Cell Responses
    Authors: Chunder, R;Schropp, V;Marzin, M;Amor, S;Kuerten, S;
    Biomedicines
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  6. Osteopontin (OPN) alleviates the progression of osteoarthritis by promoting the anabolism of chondrocytes
    Authors: Luo, W;Lin, Z;Yuan, Y;Wu, Z;Zhong, W;Liu, Q;
    Genes & diseases
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  7. Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis
    Authors: A Umemoto, T Kuwada, K Murata, M Shiokawa, S Ota, Y Murotani, A Itamoto, K Nishitani, H Yoshitomi, T Fujii, A Onishi, H Onizawa, K Murakami, M Tanaka, H Ito, H Seno, A Morinobu, S Matsuda
    Arthritis Research & Therapy, 2023-02-17;25(1):25.
    Species: Human, N/A
    Sample Types: Antibody, Protein, Whole Cells
    Applications: Bioassay, ELISA Capture
  8. Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering
    Authors: CL Gigliotti, C Dianzani, I Stoppa, C Monge, S Sutti, D Sblattero, C Puricelli, R Rolla, U Dianzani, E Boggio
    International Journal of Molecular Sciences, 2023-02-02;24(3):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  9. Osteopontin Exacerbates High-Fat Diet-Induced Metabolic Disorders in a Microbiome-Dependent Manner
    Authors: J Chen, P Zeng, L Gong, X Zhang, Z Ling, K Bi, F Shi, K Wang, Q Zhang, J Jiang, Y Zhang, T Uede, EM El-Omar, H Diao
    MBio, 2022-10-27;0(0):e0253122.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  10. Paper-based aptasensor for colorimetric detection of osteopontin
    Authors: AC Pereira, FTC Moreira, LR Rodrigues, MGF Sales
    Analytica chimica acta, 2022-01-29;1198(0):339557.
    Species: Human
    Sample Types: Recombinant Proteins
    Applications: Bioassay
  11. Smooth muscle-specific MMP17 (MT4-MMP) regulates the intestinal stem cell niche and regeneration after damage
    Authors: M Martín-Alo, S Iqbal, PM Vornewald, HT Lindholm, MJ Damen, F Martínez, S Hoel, A Díez-Sánch, M Altelaar, P Katajisto, AG Arroyo, MJ Oudhoff
    Nature Communications, 2021-11-18;12(1):6741.
    Species: Human
    Sample Types: Recombinant Protein
    Applications: Bioassay
  12. Post-Translational Regulation And Proteolytic Activity Of The Metalloproteinase Adamts8
    Authors: S Santamaria, DR Martin, X Dong, K Yamamoto, SS Apte, J Ahnström
    The Journal of Biological Chemistry, 2021-10-21;0(0):101323.
    Species: Human
    Sample Types: Protein
    Applications: Cleavage
  13. Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NF&kappaB signaling
    Authors: X Jiang, F Zhang, X Ji, F Dong, H Yu, M Xue, Y Qiu, F Yang, X Hu, Z Bao
    Cytokine, 2021-02-27;142(0):155474.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  14. The interaction between cancer associated fibroblasts and tumor associated macrophages via the osteopontin pathway in the tumor microenvironment of hepatocellular carcinoma
    Authors: K Tokuda, Y Morine, K Miyazaki, S Yamada, Y Saito, M Nishi, T Tokunaga, T Ikemoto, S Imura, M Shimada
    Oncotarget, 2021-02-16;12(4):333-343.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  15. Absence of nuclear receptors LXRs impairs immune response to androgen deprivation and leads to prostate neoplasia
    Authors: L Bousset, A Septier, J Bunay, A Voisin, R Guiton, C Damon-Soub, Y Renaud, A De Haze, V Sapin, A Fogli, A Rambur, C De Joussin, A Kocer, A Trousson, J Henry-Berg, M Höring, G Liebisch, S Matysik, JA Lobaccaro, L Morel, S Baron
    PloS Biology, 2020-12-07;18(12):e3000948.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  16. Effect of Calcium Chloride Hydrothermal Treatment of Titanium on Protein, Cellular, and Bacterial Adhesion Properties
    Authors: T Haraguchi, Y Ayukawa, Y Shibata, T Takeshita, I Atsuta, Y Ogino, N Yasunami, Y Yamashita, K Koyano
    J Clin Med, 2020-08-13;9(8):.
    Species: Human, N/A
    Sample Types: Protein, Substrate
    Applications: Bioassay, ELISA Capture
  17. Co-culture of human fibroblasts, smooth muscle and endothelial cells promotes osteopontin induction in hypoxia
    Authors: N Sadaghianl, J Contenti, M Dufies, J Parola, M Rouleau, S Lee, JF Peyron, L Fabbri, R Hassen-Kho, J Pouysségur, F Bost, E Jean-Bapti, A Dardik, NM Mazure
    J. Cell. Mol. Med., 2020-02-07;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  18. NK cells induce hepatic ER stress to promote insulin resistance in obesity through osteopontin production
    Authors: J Wu, D Wu, L Zhang, C Lin, J Liao, R Xie, Z Li, S Wu, A Liu, W Hu, Y Xi, S Bu, F Wang
    J. Leukoc. Biol., 2019-12-12;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  19. Development of a novel and rapid measurement system for growth differentiation factor-15, progranulin, and osteopontin in uterine sarcoma
    Authors: M Maeno, T Mizutani, H Tsuyoshi, S Yamada, S Ishikane, S Kawabe, K Nishimura, M Yamada, K Miyamoto, Y Yoshida
    Endocr. J., 2019-09-18;0(0):.
    Species: Human
    Sample Types: Serum
    Applications: Standard
  20. A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma
    Authors: J Song, SL Merbs, LJ Sokoll, DW Chan, Z Zhang
    Clin Proteomics, 2019-03-05;16(0):10.
    Species: Human
    Sample Types: Serum
  21. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a therapeutic target
    Authors: J Wei, A Marisetty, B Schrand, K Gabrusiewi, Y Hashimoto, M Ott, Z Grami, LY Kong, X Ling, HG Caruso, S Zhou, YA Wang, GN Fuller, JT Huse, E Gilboa, N Kang, X Huang, R Verhaak, S Li, AB Heimberger
    J. Clin. Invest., 2018-11-19;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  22. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion
    Authors: JD Klement, AV Paschall, PS Redd, ML Ibrahim, C Lu, D Yang, E Celis, SI Abrams, K Ozato, K Liu
    J. Clin. Invest., 2018-11-05;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  23. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication
    Authors: T Shirasaki, M Honda, T Yamashita, K Nio, T Shimakami, R Shimizu, S Nakasyo, K Murai, N Shirasaki, H Okada, Y Sakai, T Sato, T Suzuki, K Yoshioka, S Kaneko
    Sci Rep, 2018-09-03;8(1):13143.
    Species: Human
    Sample Types: Transfected Whole Cells
    Applications: Bioassay
  24. Osteopontin regulates HCV replication and assembly via interaction with HCV proteins and lipid droplets and by binding to receptors, αVβ3 and CD44
    Authors: J Iqbal, M Sarkar-Dut, S McRae, A Ramachandr, B Kumar, G Waris
    J. Virol., 2018-06-13;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  25. Osteopontin contributes to effective neutrophils recruitment, IL-1? production, and apoptosis in Aspergillus fumigatus keratitis
    Authors: G Zhao, M Hu, C Li, J Lee, K Yuan, G Zhu, C Che
    Immunol. Cell Biol., 2018-02-26;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  26. Psoriatic cutaneous inflammation promotes human monocyte differentiation into active osteoclasts, facilitating bone damage
    Authors: A Raimondo, S Lembo, RD Caprio, G Donnarumma, G Monfrecola, N Balato, F Ayala, A Balato
    Eur. J. Immunol., 2017-05-02;0(0):.
    Species: Human
    Sample Types: Whole Tissue
    Applications: Bioassay
  27. Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis
    PLoS ONE, 2016-12-19;11(12):e0167141.
    Species: Human
    Sample Types: Urine
    Applications: ELISA (Standard)
  28. Trametinib Drives T-cell-Dependent Control of KRAS-Mutated Tumors by Inhibiting Pathological Myelopoiesis
    Cancer Res., 2016-11-01;76(21):6253-6265.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  29. Phosphorylation of osteopontin has proapoptotic and proinflammatory effects on human knee osteoarthritis chondrocytes
    Authors: Guang-Hua Lei
    Exp Ther Med, 2016-10-05;12(5):3488-3494.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  30. Alcohol inhibits osteopontin-dependent transforming growth factor-beta1 expression in human mesenchymal stem cells.
    Authors: Driver J, Weber C, Callaci J, Kothari A, Zapf M, Roper P, Borys D, Franzen C, Gupta G, Wai P, Zhang J, Denning M, Kuo P, Mi Z
    J Biol Chem, 2015-02-24;290(16):9959-73.
    Species: Human
    Sample Types: Protein, Whole Cells
    Applications: Bioassay
  31. Osteopontin mediates an MZF1-TGF-beta1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.
    Authors: Weber C, Kothari A, Wai P, Li N, Driver J, Zapf M, Franzen C, Gupta G, Osipo C, Zlobin A, Syn W, Zhang J, Kuo P, Mi Z
    Oncogene, 2014-12-22;34(37):4821-33.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  32. OPN induces FoxM1 expression and localization through ERK 1/2, AKT, and p38 signaling pathway in HEC-1A cells.
    Authors: Xie, Yunpeng, Li, Yinghua, Kong, Ying
    Int J Mol Sci, 2014-12-16;15(12):23345-58.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  33. Cell stress induces upregulation of osteopontin via the ERK pathway in type II alveolar epithelial cells.
    Authors: Kato, Aki, Okura, Takafumi, Hamada, Chizuru, Miyoshi, Seigo, Katayama, Hitoshi, Higaki, Jitsuo, Ito, Ryoji
    PLoS ONE, 2014-06-25;9(6):e100106.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  34. Osteopontin is induced by TGF-beta2 and regulates metabolic cell activity in cultured human optic nerve head astrocytes.
    Authors: Neumann C, Garreis F, Paulsen F, Hammer C, Birke M, Scholz M
    PLoS ONE, 2014-04-09;9(4):e92762.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  35. Role of hepatitis C virus induced osteopontin in epithelial to mesenchymal transition, migration and invasion of hepatocytes.
    Authors: Iqbal J, McRae S, Mai T, Banaudha K, Sarkar-Dutta M, Waris G
    PLoS ONE, 2014-01-31;9(1):e87464.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  36. Dual regulation of osteopontin production by TLR stimulation in dendritic cells.
    Authors: Salvi V, Scutera S, Rossi S, Zucca M, Alessandria M, Greco D, Bosisio D, Sozzani S, Musso T
    J Leukoc Biol, 2013-04-22;94(1):147-58.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  37. Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia.
    Authors: Barros N, Hoac B, Neves R, Addison W, Assis D, Murshed M, Carmona A, McKee M
    J Bone Miner Res, 2013-03-01;28(3):688-99.
    Applications: Bioassay
  38. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
    Authors: Shojaei F, Scott N, Kang X, Lappin PB, Fitzgerald AA, Karlicek S, Simmons BH, Wu A, Lee JH, Bergqvist S, Kraynov E
    J. Exp. Clin. Cancer Res., 2012-03-23;31(0):26.
    Species: Human
    Sample Types: Antibody, Recombinant Protein
    Applications: Binding Assay, Surface Plasmon Resonance
  39. Secreted osteopontin is highly polymerized in human airways and fragmented in asthmatic airway secretions.
    Authors: Arjomandi M, Frelinger J, Donde A
    PLoS ONE, 2011-10-21;6(10):e25678.
    Applications: Bioassay
  40. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
    Authors: Chu M, Yang P, Hu R, Hou S, Li F, Chen Y, Kijlstra A
    Invest. Ophthalmol. Vis. Sci., 2011-09-09;52(10):7084-9.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  41. Adhesion of human haematopoietic (CD34+) stem cells to human liver compartments is integrin and CD44 dependent and modulated by CXCR3 and CXCR4.
    Authors: Crosby HA, Lalor PF, Ross E, Newsome PN, Adams DH
    J. Hepatol., 2009-07-30;51(4):734-49.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  42. Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma.
    Authors: Simoes DC, Xanthou G, Petrochilou K, Panoutsakopoulou V, Roussos C, Gratziou C
    Am. J. Respir. Crit. Care Med., 2009-02-20;179(10):894-902.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  43. Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin.
    Authors: Shao J, Washington MK, Saxena R, Sheng H
    Carcinogenesis, 2007-08-11;28(12):2476-83.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs
Loading...

Reviews for Recombinant Human Osteopontin (OPN) Protein

Average Rating: 4.5 (Based on 2 Reviews)

5 Star
50%
4 Star
50%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Recombinant Human Osteopontin (OPN) Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Recombinant Human Osteopontin (OPN) Protein
By Alicia Furlan on 05/15/2024
Application: Immunoassay Standard
Reason for Rating: Worked well with the corresponding Quantikine kit.
Recombinant Human Osteopontin (OPN) Protein
By Anonymous on 08/21/2019
Application: In vitro bioactivity in cell culture